Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial Disease

NCT05218655 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT05218655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05218655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial Disease
Lead sponsor
PTC Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
June 22, 2022
Completion date
April 15, 2025
Enrollment
101 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

inherited mitochondrial disease